Literature DB >> 16982258

Acquired nasolacrimal duct obstruction.

David M Mills1, Dale R Meyer.   

Abstract

Acquired nasolacrimal duct obstruction is a common problem. Although tearing is the usual complaint, the clinical presentation can range from a patient having no symptoms to one with a life-threatening infection. Despite many studies providing useful clues, the exact pathophysiology of the obstructive process is incompletely understood. The clinician must be able to accurately make the diagnosis, which is often a clinical one, because many treatments with excellent success are available.

Entities:  

Mesh:

Year:  2006        PMID: 16982258     DOI: 10.1016/j.otc.2006.07.002

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  5 in total

1.  UK survey of the present role of ear, nose and throat surgeons in lacrimal surgery.

Authors:  Salim Al-Shaikh; Faisal Javed; Gregory Fincham; Mohamed Latif; Mahmood Bhutta
Journal:  Ann R Coll Surg Engl       Date:  2010-07-13       Impact factor: 1.891

2.  Three-dimensional volumetric assessment of the nasolacrimal duct in patients with obstruction.

Authors:  Jaclyn L Estes; Apostolos J Tsiouris; Paul J Christos; Gary J Lelli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2015 May-Jun       Impact factor: 1.746

3.  Associated morbidity of nasolacrimal duct obstruction--a large community based case-control study.

Authors:  Arie Y Nemet; Shlomo Vinker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-22       Impact factor: 3.117

4.  An Unusual Case of Nasolacrimal Obstruction Caused by Foodstuffs.

Authors:  Hirohiko Matsumoto; Akiyo Matsumoto
Journal:  Case Rep Ophthalmol       Date:  2015-09-04

5.  Application of a symptoms score questionnaire after conjunctivodacryocystorhinostomy: outcomes.

Authors:  Andrea Iandelli; Andrea Luigi Camillo Carobbio; Renata Migliardi; Maurizio Catalani; Francesco Mazzola; Giampiero Parrinello; Giorgio Peretti; Frank Rikki Canevari
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-06       Impact factor: 2.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.